Mechanistically, CREB3L1 overexpression can facilitate the dedifferentiation of papillary thyroid cancer cells into ATC cells, and promote thyroid cancer progression by regulating EMT process and the mTOR signaling pathway (Luo et al., 2021). Here, CREB3L1 is linked to thyroid gland carcinoma.